Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023979 |
---|---|
Receipt number | R000026911 |
Scientific Title | Phase 1/2 clinical trial to evaluate the safety and efficacy of daily intravitreal injections of KUS121 for three days in patients with non-arteritic central retinal artery occlusion |
Date of disclosure of the study information | 2016/09/15 |
Last modified on | 2018/03/13 10:28:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/09/08 12:44:30 | ||
2 | Update | 2016/09/09 16:42:03 | Anticipated trial start date |
|
3 | Update | 2016/09/09 16:42:54 | Date of disclosure of the study information |
|
4 | Update | 2016/10/27 17:40:41 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2016/11/04 16:23:46 | Recruitment status Anticipated trial start date |
|
6 | Update | 2016/11/18 14:43:04 | Condition |
|
7 | Update | 2018/02/19 17:02:10 | Recruitment status Last follow-up date |
|
8 | Update | 2018/03/13 10:28:39 | Recruitment status Date trial data considered complete Date analysis concluded |